Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERISCOPE: Pioglitazone vs Glimepiride in T2DM
NCT00225277Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2003
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Jul 2003; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00225277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225277.